The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CI | -2.14% | +86.38% | +13.26% | +13,914% |
| S&P | +15.06% | +95.03% | +14.29% | +5,819% |
The Cigna Group is engaged in the provision of global health services. It operates through the following segments: Evernorth, U.S. Medical, International Markets, and Group Disability and Other. The Evernorth segment includes a broad range of coordinated and point solution health services, including pharmacy solutions, benefits management solutions, care solutions and intelligence solutions. The U.S. Medical segment includes Cigna's U.S. Commercial and U.S. Government businesses that provide comprehensive medical and coordinated solutions to clients and customers. The International Markets segment includes supplemental health, life and accident insurance products and health care coverage in international markets, as well as health care benefits to globally mobile employees of multinational organizations. The Group Disability and Other segment represents group disability and life, corporate-owned life insurance, and run-off business consisting of reinsurance, settlement authority, and individual life insurance and annuity and retirement benefits business. The company was founded in 1792 and is headquartered in Bloomfield, CT.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $67.23B | 11.2% |
| Market Cap | $88.31B | -6.0% |
| Market Cap / Employee | $1.20M | 0.0% |
| Employees | 73.5K | 1.4% |
| Net Income | $1.63B | 0.2% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $4.33B | -36.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $26.48B | -12.2% |
| Short Term Debt | $4.29B | 149.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 3.37% | 0.9% |
| Return On Invested Capital | 7.66% | -0.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2,171.00M | -1967.6% |
| Operating Free Cash Flow | -$1,886.00M | -811.7% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 32.68 | 22.57 | 18.23 | 18.05 | -30.57% |
| Price to Book | 2.34 | 1.83 | 2.20 | 2.22 | -2.77% |
| Price to Sales | 0.42 | 0.31 | 0.35 | 0.34 | -21.93% |
| Price to Tangible Book Value | -2.93 | -2.41 | -1.45 | -2.69 | -3.95% |
| Price to Free Cash Flow TTM | 26.76 | 10.38 | 20.26 | 37.61 | 158.22% |
| Free Cash Flow Yield | 3.7% | 9.6% | 4.9% | 2.7% | -61.27% |
| Return on Equity | 6.9% | 7.9% | 12.4% | 12.3% | 44.01% |
| Total Debt | $32.80B | $31.97B | $30.45B | $30.77B | -3.52% |
CI earnings call for the period ending December 31, 2024.
CI earnings call for the period ending September 30, 2024.
CI earnings call for the period ending June 30, 2024.
CI earnings call for the period ending March 31, 2024.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
